October 5, 2022

BOC Sciences is ready for the mass production of complex peptides with a complete synthesis platform

With more than ten years of experience in peptide development, BOC Sciences has established a world-leading solid/liquid phase synthesis technology platform to manufacture new complex peptides.

New York, United States – July 29, 2022 – BOC Sciences publicly presents itself as a supplier of peptides that have passed the GMP certification of the United States and the European Union. He focused on the development of advanced synthetic technologies to solve a series of complex peptide modification problems. After years of dedication, a comprehensive peptide synthesis platform has been built to provide solid/liquid phase synthesis support for global customers.

Peptide synthesis has become a more practical part of current scientific research following the advent of solid phase techniques. BOC Sciences displays excellent capabilities in this technique. “Reactions are driven to completion by the use of excess soluble reagents, which can be removed by simple filtration and washing without handling losses. Once the chain elongation is complete, the crude peptide is released from the support,” explained the chief technician of BOC Sciences on the essence of the solid-phase approach.

Classical or liquid phase methods for peptide synthesis also have an elegant history and have been well documented. BOC Sciences typically uses liquid-phase synthesis to synthesize large-scale peptides, polymeric peptides, and difficult peptides, making unique contributions to mass manufacturing for specialized laboratory or industrial applications.

Thanks to the constant and joint efforts of BOC Sciences and its peers, a number of synthetic peptides are now becoming important pharmaceuticals. According to a report published by BOC Sciences, its peptide technology platform supports the synthesis of the following peptides:

1) Ordinary and long chain linear peptides

Purity: 99% crude

Length: 2-200AA

Scale: milligrams to kilograms

Success rate: > 95%

2) Cyclic Peptides

Type: disulfide peptide, click peptide, lactam cyclization, bicyclic peptide, etc.

Position of cycling: head-tail, head-warp side, warp side-warp side, warp side-tail

3) Labeling and modification of peptides

Modification of phosphorylation

Fluorescence/dye labeling

Amidation (C-terminal) or acetylation (N-terminal)

Special amino acid modifications, such as amino acid derivatives, etc.

Other modifications: modification of polyethylene glycol, modification of biotin, etc.

The market for therapeutic peptides has so far reached the level of several billion dollars. A rapid, efficient and reliable methodology for the chemical synthesis of these molecules is therefore of the highest value. BOC Sciences, equipped with the advanced peptide synthesis platform, is happy to become one of the contributors.

Besides the peptide synthesis platform, BOC Sciences is also committed to providing unique technology platforms that can meet various chemical synthesis needs. For more information on the main CDMO, go to https://cdmo.bocsci.com.


BOC Sciences is a certified CDMO partner who can facilitate most aspects of drug development. He works with many pharmaceutical and biotechnology companies to bring about positive advancements in the pharmaceutical industry.

Media Contact
Company Name: BOC Science
Contact person: Alex Brown
E-mail: Send an email
Call: 1-631-485-4226
Country: United States
Website: https://cdmo.bocsci.com